Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation (PROTECT)

The PROTECT Study: Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation

The proposed study assesses the superiority of IES supplementation to the standard of care alone (offloading pressure every two hours) in improving the prevention and treatment of sacral and ischial pressure injuries.

Study Overview

• Status: Terminated
• Conditions: Pressure Injury
• Intervention / Treatment: Device: IES System; Other: Standard of Care Therapy

• Study Type: Interventional
• Enrollment (Actual): 4
• Phase: Phase 3

Contacts and Locations

Study Locations

• Canada
  • Alberta
    • Edmonton, Alberta, Canada, T6G 1Z2
      • Cross Cancer Institute

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Modified Braden Scale score of 14 or less. The Modified Braden Scale score is calculated as follows:

   Braden Scale score (Ranges from 6 to 23)

   • 1 for Low Serum Albumin
   • 1 for Type II Diabetes
2. Anticipated length of stay of at least 4 days
3. BMI < 35
4. Participants capable of giving informed consent, or if appropriate, participants having an acceptable individual capable of giving consent on the participant's behalf.

Exclusion Criteria:

1. Existing pressure injuries above Stage II and injuries classified as DTI or unstageable
2. Neuromuscular blocking drugs & myasthenia gravis: may prevent the ability of electrical stimulation to induce muscular contraction
3. Unstable spinal, pelvic, or hip fractures that may be displaced by a forced contraction
4. Rhabdomyolysis
5. Use of a Pacemaker
6. Skin breakdown over the gluteal regions that would preclude the use of surface electrodes.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: IES Device + Standard of Care; Intermittent electrical stimulation system. Charged pulses will be administered to bilateral gluteus maximus through surface electrodes. Stimulation occurs at 30 Hz for 10s every 10 minutes. The intervention is administered 24/7 and added to the standard of care management. Standard of care is defined as turning the patient every two hours.	Device: IES System; The IES system is composed of a stimulator and self-adhesive surface gel electrodes.; Other: Standard of Care Therapy; Standard institutional practices for treating pressure injury.
Active Comparator: Standard of Care; Standard of care treatment for pressure injuries is turning the patient every two hours.	Other: Standard of Care Therapy; Standard institutional practices for treating pressure injury.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Clinical course of pressure injury over time	Chauhan Weighted Trajectory Analysis (CWTA) will be used to compare the morbidity associated with sacral and ischial pressure injuries through time. A one-sided Chauhan logrank test at a significance of 0.05 will be used to assess for superiority of the experimental arm over the control arm.	Patients will be assessed daily for pressure injury location and stage through treatment completion, an average of 14 days.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Clinical course of pressure injury in subgroups	Chauhan Weighted Trajectory Analysis (CWTA) will be used to compare the morbidity associated with sacral and ischial pressure injuries through time. A one-sided Chauhan logrank test at a significance of 0.05 will be used to assess superiority.	Patients will be assessed daily for pressure injury location and stage through treatment completion, an average of 14 days.
Kaplan-Meier Time-to-Event Analysis	A Kaplan Meier Curve and logrank Test (one-sided significance at p < 0.05) will be used to evaluate a difference in sacral and ischial pressure injury time-to-event morbidity between groups. An "event" is defined as the development of any stage/class of pressure ulcer.	Final analysis will be performed at end of study (expected completion 2 years)
Cox Regression Analysis	Cox-regression analysis will be used to determine whether the implementation of the IES device is associated with a significant difference in sacral and ischial pressure injury time-to-event occurrence between treatment groups.	Final analysis will be performed at end of study (expected completion 2 years)
Observed Counts of Pressure Injuries	Descriptive statistics and Chi-square testing will be used to compare in incidence rates and proportion between the treatment groups for sacral and ischial pressure injuries classified as Stage I-IV or Unstageable	Final analysis will be performed at end of study (expected completion 2 years)
Onset Time	Descriptive statistics will be used to report the central tendency and spread of the onset time of a sacral and ischial pressure injury for both treatment groups and for injuries classified as Stage I-IV or Unstageable	Final analysis will be performed at end of study (expected completion 2 years)
Relative Risk	Relative risk of sacral and ischial pressure injuries will be compared between treatment groups using a 2x2 contingency table with a 95% confidence interval.	Final analysis will be performed at end of study (expected completion 2 years)
Duration of Inpatient Stay	Descriptive statistics will be used to report the central tendency and spread of the duration of inpatient stay for both treatment groups	Final analysis will be performed at end of study (expected completion 2 years)
Description of adverse events related to IES	We will report frequency and severity of skin changes underlying the electrodes, categorized as i) transient erythema after electrode removal, ii) non-transient skin changes after electrode removal, iii) skin breakdown under electrode.	Final analysis will be performed at end of study (expected completion 2 years)

Collaborators and Investigators

• Sponsor: AHS Cancer Control Alberta
• Collaborators: Rehabtronics

Study record dates

Study Major Dates

• Study Start (Actual): February 26, 2021
• Primary Completion (Actual): March 14, 2022
• Study Completion (Actual): March 14, 2022

Study Registration Dates

• First Submitted: March 26, 2020
• First Submitted That Met QC Criteria: March 27, 2020
• First Posted (Actual): March 31, 2020

Study Record Updates

• Last Update Posted (Estimate): January 11, 2023
• Last Update Submitted That Met QC Criteria: January 10, 2023
• Last Verified: March 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Wounds and Injuries; Crush Injuries
• Other Study ID Numbers: IIT-0018

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No